Canadian Medical Center Co. (CMCER) recorded a net profit of SAR 7.4 million for Q1 2025, against a loss of SAR 221,000 a year earlier.
| Item | Q1 2024 | Q1 2025 | Change |
|---|---|---|---|
| Revenues | 24.32 | 30.09 | 23.7 % |
| Gross Income | 4.38 | 8.85 | 102.0 % |
| Operating Income | 0.14 | 5.19 | 3650.3 % |
| Net Income | (0.22) | 7.45 | 3472.0 % |
| Average Shares | 77.00 | 77.00 | - |
| Earnings Per Share before unusual items (Riyal) | 0.00 | 0.06 | 2138.6 % |
| EPS (Riyal) | 0.00 | 0.10 | 3472.0 % |
| Item | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Revenues | 30.36 | 30.09 | (0.9 %) |
| Gross Income | 9.77 | 8.85 | (9.5 %) |
| Operating Income | 5.00 | 5.19 | 3.7 % |
| Net Income | 4.47 | 7.45 | 66.7 % |
| Average Shares | 77.00 | 77.00 | - |
| Earnings Per Share before unusual items (Riyal) | 0.06 | 0.06 | 0.8 % |
| EPS (Riyal) | 0.06 | 0.10 | 66.7 % |
The profit growth was attributed to an increase in sales during the current quarter, which led to a 23.7% year-on-year (YoY) growth in revenue. This represents the highest quarterly revenue in the company’s history thanks to the initial positive results of the expansionary “Transformation Plan” announced last year.
The plan aimed to diversify income sources and achieve growth and sustainability in both revenue and profits, by shifting the company’s focus from providing medical services solely to the oil and gas sector to targeting new sectors, expanding into new cities, and introducing new medical services.
The company also reported an increase in gross profit margin to 29.4%, compared to 18% in the Q1 2024, a rise of 11.4%.
In addition, the company’s investment portfolio achieved a return of 8.36% during the first quarter.
On a quarterly basis, net income surged 3472% against a loss of SAR 221,000 in Q1 2024.
Total shareholders’ equity, no minority interest, rose to SAR 96.89 million as of March 31, 2025, compared to SAR 84.12 million a year earlier.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: